Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) EPS (Basic) (2022 - 2025)

Envoy Medical's EPS (Basic) history spans 4 years, with the latest figure at -$0.35 for Q3 2025.

  • For Q3 2025, EPS (Basic) rose 11.32% year-over-year to -$0.35; the TTM value through Sep 2025 reached -$0.35, up 87.6%, while the annual FY2024 figure was -$1.07, 55.12% up from the prior year.
  • EPS (Basic) for Q3 2025 was -$0.35 at Envoy Medical, down from -$0.32 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.23 in Q1 2022 and bottomed at -$1.31 in Q2 2023.
  • The 4-year median for EPS (Basic) is -$0.29 (2025), against an average of -$0.38.
  • The largest YoY upside for EPS (Basic) was 200.0% in 2023 against a maximum downside of 2283.33% in 2023.
  • A 4-year view of EPS (Basic) shows it stood at -$1.13 in 2022, then dropped by 7.96% to -$1.22 in 2023, then soared by 78.48% to -$0.26 in 2024, then tumbled by 31.75% to -$0.35 in 2025.
  • Per Business Quant, the three most recent readings for COCH's EPS (Basic) are -$0.35 (Q3 2025), -$0.32 (Q2 2025), and -$0.29 (Q1 2025).